Chemomab Therapeutics (CMMB)
(Real Time Quote from BATS)
$1.13 USD
+0.01 (0.89%)
Updated Jul 22, 2024 11:50 AM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Chemomab Therapeutics Ltd. Sponsored ADR [CMMB]
Reports for Purchase
Showing records 1 - 10 ( 10 total )
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
PSC Ph 2 Enrollment Completes Early Accelerating Top-line Results to Mid-Year
Provider: Roth Capital Partners, Inc.
Analyst: WHITE J
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Resuming Coverage with a Buy and $7 PT
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Biotechnology -Healthcare Coverage Update
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
|